<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR29">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kumar</surname>
    <given-names>SK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib</article-title>
  <source>Blood</source>
  <year>2016</year>
  <volume>128</volume>
  <fpage>2415</fpage>
  <lpage>2422</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2016-05-717769</pub-id>
  <?supplied-pmid 27702799?>
  <pub-id pub-id-type="pmid">27702799</pub-id>
 </element-citation>
</ref>
